Current Emergency and Hospital Medicine Reports

, Volume 7, Issue 4, pp 214–226 | Cite as

Haemodynamic Assessment in Cardiogenic Shock

  • Hoong Sern LimEmail author
Cardiovascular Care (L Roever, Section Editor)
Part of the following topical collections:
  1. Topical Collection on Cardiovascular Care


Purpose of Review

This review will discuss the practical applications based on the physiology that underpins some of these commonly used haemodynamic parameters.

Recent Findings

Haemodynamic parameters are integral to the management of cardiogenic shock. Some of these are easily measured and ubiquitous, such as arterial blood pressure and central venous pressure. Others, such as the use of pulmonary artery catheters, continue to be discussed and debated.


The management of cardiogenic shock is challenging. Clinicians employ a range of haemodynamic parameters to diagnose and guide therapeutic interventions in cardiogenic shock. Understanding the physiologic basis for these parameters will aid the interpretation and clinical application in cardiogenic shock.


Cardiogenic shock Blood pressure Cardiac output 


Compliance with Ethical Standards

Conflict of Interest

Hoong Sern Lim declares no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.


Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. 1.
    Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2016;37:2129–200.PubMedGoogle Scholar
  2. 2.
    Kato R, Pinsky MR. Personalizing blood pressure management in septic shock. Ann Intensive Care. 2015;5:41–50.PubMedPubMedCentralGoogle Scholar
  3. 3.
    Magder S. Starling resistor versus compliance. Which explains the zero-flow pressure of a dynamic arterial pressure-flow relation? Circ Res. 1981;49:980–7.Google Scholar
  4. 4.
    • Maas JJ, de Wilde RB, Aarts LP, Pinsky MR, Jansen JR. Determination of vascular waterfall phenomenon by bedside measurement of mean systemic lling pressure and critical closing pressure in the intensive care unit. Anesth Analg. 2012;114:803–10. This study demonstrates the vascular waterfall in human physiology. PubMedPubMedCentralGoogle Scholar
  5. 5.
    Klima UP, Guerrero JL, Vlahakes GJ. Myocardial perfusion and right ventricular function. Ann Thorac Cardiovasc Surg. 1999;5:74–80.PubMedGoogle Scholar
  6. 6.
    Gelman S, Mushlin PS. Catecholamine-induced changes in the splanchnic circulation affecting systemic hemodynamics. Anesthesiology. 2004;100:434–9.PubMedGoogle Scholar
  7. 7.
    Maas JJ, Pinsky MR, de Wilde RB, de Jonge E, Jansen JR. Cardiac output response to norepinephrine in postoperative cardiac surgery patients: interpretation with venous return and cardiac function curves. Crit Care Med. 2013;41:143–50.PubMedGoogle Scholar
  8. 8.
    Magder S, Veerassamy S, Bates JHT. A further analysis of why pulmonary venous pressure rises after the onset of LV dysfunction. J Appl Physiol. 2009;106:81–90.PubMedGoogle Scholar
  9. 9.
    Thiele RH, Nemergut EC, Lynch C III. The physiologic implications of isolated alpha 1 adrenergic stimulation. Anesth Analg. 2011;113:284–96.PubMedGoogle Scholar
  10. 10.
    Den Uil CA, Lagrand WK, van der Ent M, et al. Impaired microcirculation predicts poor outcome of patients with acute myocardial infarction complicated by cardiogenic shock. Eur Heart J. 2010;31:3032–9.Google Scholar
  11. 11.
    Lim HS. Cardiogenic shock: failure of oxygen delivery and utilization. Clin Cardiol. 2016;39:477–83.PubMedPubMedCentralGoogle Scholar
  12. 12.
    • Cecconi M, De Backer D, Antonelli M, Beale R, Bakker J, Hofer C, et al. Consensus on circulatory shock and hemodynamic monitoring. Task Force of the European Society of Intensive Care Medicine. Intensive Care Med. 2014;40:1795–815. A key consensus paper that details the hemodynamic minotoring in circulatory shock. PubMedPubMedCentralGoogle Scholar
  13. 13.
    Magder S. Right atrial pressure in the critically ill. How to measure, what is the value, what are the limitations? Chest. 2017;151:908–16.PubMedGoogle Scholar
  14. 14.
    Lodato RF. Use of the pulmonary artery catheter. Semin Respir Crit Care Med. 1999;20:29–42.Google Scholar
  15. 15.
    Magder S. Central venous pressure monitoring. Curr Opin Crit Care. 2006;12:219–27.PubMedGoogle Scholar
  16. 16.
    Guyton AC, Abernathy B, Langston JB, Kaufmann BN, Fairchild HM. Relative importance of venous return and arterial resistances in cotrolling venous return and cardiac output. Am J Phys. 1959;196:1008–14.Google Scholar
  17. 17.
    Magder S, Bafaqeeh F. The clinical role of central venous pressure measurements. J Intensive Care Med. 2007;22:44–51.PubMedGoogle Scholar
  18. 18.
    Marik PE, Baram M, Vahid B. Does central venous pressure predict fluid responsiveness? A systematic review of the literature and the tale of seven mares. Chest. 2008;134:172–8.PubMedGoogle Scholar
  19. 19.
    Michard F, Teboul JL. Predicting fluid responsiveness in ICU patients. A critical analysis of the evidence. Chest. 2002;121:2000–8.PubMedGoogle Scholar
  20. 20.
    Magder S, Erice F, Lagonidis D. Determinants of the ‘y’ descent and its use- fulness as a predictor of ventricular filling. J Intensive Care Med. 2000;15:262–9.Google Scholar
  21. 21.
    Shah MR, Hasselbald V, Stevenson LW, et al. Impact of the pulmonary artery catheter in critically ill patients: meta-analysis of randomized clinical trials. JAMA. 2005;294:1664–70.PubMedGoogle Scholar
  22. 22.
    Murphy GS, Vender JS. Con: is the pulmonary artery catheter dead? J Cardiothorac Vasc Anesth. 2007;21:147–9.PubMedGoogle Scholar
  23. 23.
    Mackenzie JD, Haites NA, Rawles JM. Method of assessing the reproducibility of blood flow measurement: factors influencing the performance of thermo-dilution cardiac output computers. Br Heart J. 1986;55:14–24.PubMedPubMedCentralGoogle Scholar
  24. 24.
    Sanmarco ME, Philips CM, Marquez LA, Hall C, Davila JC. Measurement of cardiac output by thermal dilution. Am J Cardiol. 1971;28:54–8.PubMedGoogle Scholar
  25. 25.
    Stctz WC, Miller RG, Kelly GE, Raffin TA. Reliability of the thermodilution method of determining cardiac output in clinical practice. Am Rev Respir Dis. 1982;26:1001–4.Google Scholar
  26. 26.
    Chiolero R, Flatt JP, Revelly JP, Jequier E. Effects of catecholamines on oxygen consumption and oxygen delivery in critically ill patients. Chest. 1991;100:1676–84.PubMedGoogle Scholar
  27. 27.
    Teboul JL, Mercat A, Lenique F, Berton C, Richard C. Value of the venous-arterial PCO2 gradient to reflect the oxygen supply to demand in humans: effects of dobutamine. Crit Care Med. 1998;26:1007–10.PubMedGoogle Scholar
  28. 28.
    Teboul JL, Graini L, Boujdaria R, Berton C, Richard C. Cardiac index versus oxygen-derived parameters for rational use of dobutamine in patients with congestive heart failure. Chest. 1993;103:81–5.PubMedGoogle Scholar
  29. 29.
    Fares WH, Blanchard SK, Stouffer GA, Chang PP, Rosamond WD, Ford HJ, et al. Thermodilution and Fick cardiac outputs differ: impact on pulmonary hypertension evaluation. Can Respir J. 2012;19:261–6.PubMedPubMedCentralGoogle Scholar
  30. 30.
    Meital V, Izak G, Rachmilewitz M. Changes in iron mobilization and utilization induced by acute haemorrhage. Br J Haematol. 1966;12:598–610.PubMedGoogle Scholar
  31. 31.
    Gleiter CH, Freudenthaler S, Delabar U, Eckardt KU, Muhlbauer B, Gundert-Remy U, et al. Erythropoietin production in healthy volunteers subjected to controlled haemorrhage: evidence against a major role for adenosine. Br J Clin Pharmacol. 1996;42:729–35.PubMedPubMedCentralGoogle Scholar
  32. 32.
    Gleiter CH, Becker T, Schreeb KH, Freudenthaler S, Gundert-Remy U. Fenoterol but not dobutamine increases erythropoietin production in humans. Clin Pharmacol Ther. 1997;61:669–76.PubMedGoogle Scholar
  33. 33.
    Nelson DP, King CE, Dodd SL, Schumacker PT, Cain SM. Systemic and intestinal limits of O2 extraction in the dog. J Appl Physiol. 1987;63:387–94.PubMedGoogle Scholar
  34. 34.
    Samsel RW, Nelson DP, Sanders WM, Wood LD, Schumacker PT. Effect of endotoxin on systemic and skeletal muscle O2 extraction. J Appl Physiol. 1988;65:1377–82.PubMedGoogle Scholar
  35. 35.
    Bredle DL, Samsel RW, Schumacker PT, Cain SM. Critical O2 delivery to skeletal muscle at high and low Po2 in endotoxemic dogs. J Appl Physiol. 1989;66:2553–8.PubMedGoogle Scholar
  36. 36.
    Nelson DP, Samsel RW, Wood LD, Schumacker PT. Pathological supply dependence of systemic and intestinal O2 uptake during endotoxemia. J Appl Physiol. 1988;64:2410–9.PubMedGoogle Scholar
  37. 37.
    Walley KR, Becker CJ, Hogan RA, Teplinsky K, Wood LD. Progressive hypoxemia limits left ventricular oxygen consumption and contractility. Circ Res. 1988;63:849–59.PubMedGoogle Scholar
  38. 38.
    Weyne J, De Ley G, Demeester G, Vandecasteele C, Vermeulen FL, Donche H, et al. Pet studies of changes in cerebral blood flow and oxygen metabolism after unilateral microembolization of the brain in anesthetized dogs. Stroke. 1987;18:128–37.PubMedGoogle Scholar
  39. 39.
    Walley KR. Heterogeneity of oxygen delivery impairs oxygen extraction by peripheral tissues: theory. J Appl Physiol. 1996;81:885–94.PubMedGoogle Scholar
  40. 40.
    Sakr Y, Dubois MJ, De Backer D, Creteur J, Vincent JL. Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock. Crit Care Med. 2004;32:1825–31.PubMedGoogle Scholar
  41. 41.
    Protti A, Singer M. Bench-to-bedside review: potential strategies to protect or reverse mitochondrial dysfunction in sepsis-induced organ failure. Crit Care. 2006;10:228.PubMedPubMedCentralGoogle Scholar
  42. 42.
    Nakazawa K, Hikawa Y, Saitoh Y, Tanaka N, Yasuda K, Amaha K. Usefulness of central venous oxygen saturation monitoring during cardiopulmonary resuscitation. A comparative case study with end-tidal carbon dioxide monitoring. Intensive Care Med. 1994;20:450–1.PubMedGoogle Scholar
  43. 43.
    Rivers EP, Martin GB, Smithline H, Rady MY, Schultz CH, Goetting MG, et al. The clinical implications of contin- uous central venous oxygen saturation during human CPR. Ann Emerg Med. 1992;21:1094–101.PubMedGoogle Scholar
  44. 44.
    Rivers EP, Rady MY, Martin GB, Fenn NM, Smithline HA, Alexander ME, et al. Venous hyperoxia after cardiac arrest. Characterization of a defect in systemic oxygen utilization. Chest. 1992;102:1787–93.PubMedGoogle Scholar
  45. 45.
    Muir AL, Kirby BJ, King AJ, Miller HC. Mixed venous oxygen saturation in relation to cardiac output in myocardial infarction. BMJ. 1970;4:276–8.PubMedGoogle Scholar
  46. 46.
    Dahn M, Lange M, Jacobs L. Central mixed and splanchnic venous oxygen saturation monitoring. Intensive Care Med. 1988;14:373–8.PubMedGoogle Scholar
  47. 47.
    Barratt-Boyes B, Wood E. The oxygen saturation of blood in the venae cavae, right-heart chambers and pulmonary vessels of healthy subjects. J Lab Clin Med. 1957;50:93–106.PubMedGoogle Scholar
  48. 48.
    Glamann D, Lange R, Hillis L. Incidence and significance of a “step-down” in oxygen saturation from superior vena cava to pulmonary artery. Am J Cardiol. 1991;68:695–7.PubMedGoogle Scholar
  49. 49.
    Vesely TM. Central venous catheter tip position: a continuing controversy. J Vasc Interv Radiol. 2003;14:527–34.PubMedGoogle Scholar
  50. 50.
    Reinhart K, Kersting T, Fohring U, et al. Can central-venous replace mixed- venous oxygen saturation measurements during anesthesia? Adv Exp Med Biol. 1986;200:67–72.PubMedGoogle Scholar
  51. 51.
    Meier-Hellmann A, Reinhart K, Bredle DL, Specht M, Spies CD, Hannemann L. Epinephrine impairs splanchnic perfusion in septic shock. Crit Care Med. 1997;25:399–404.PubMedGoogle Scholar
  52. 52.
    Chawla L, Zia H, Gutierrez G, Katz N, Seneff M, Shah M. Lack of equiva- lence between central and mixed venous oxygen saturation. Chest. 2004;126:1891–6.PubMedGoogle Scholar
  53. 53.
    Ho K, Harding R, Chamberlain J, Bulsara M. A comparison of central and mixed venous oxygen saturation in circulatory failure. J Cardiothorac Vasc Anesth. 2010;24:434–9.PubMedGoogle Scholar
  54. 54.
    Varpula M, Karlsson S, Ruokonen E. Mixed venous oxygen saturation cannot be estimated by central venous oxygen saturation in septic shock. Intensive Care Med. 2006;32:1336–43.PubMedGoogle Scholar
  55. 55.
    Scheinman MM, Brown MA, Rapaport E. Critical assessment of use of central venous oxygen saturation as a mirror of mixed venous oxygen in severely ill cardiac patients. Circulation. 1969;40:165–70.PubMedGoogle Scholar
  56. 56.
    Lee J, Wright F, Barber R, Stanley L. Central venous oxygen saturation in shock: a study in man. Anesthesiology. 1972;36:472–8.PubMedGoogle Scholar
  57. 57.
    Tahvanainen J, Meretoja O, Nikki P. Can central venous blood replace mixed venous blood samples? Crit Care Med. 1982;10:758–61.PubMedGoogle Scholar
  58. 58.
    Ladakis C, Myrianthefs P, Karabinis A, Karatzas G, Dosios T, Fildissis G, et al. Central venous and mixed venous oxygen saturation in critically ill patients. Respiration. 2001;68:279–85.PubMedGoogle Scholar
  59. 59.
    Goldman RH, Braniff B, Harrison DC, et al. The use of central venous oxygen saturation measurements in a coronary care unit. Ann Intern Med. 1968;68:1280–7.PubMedGoogle Scholar
  60. 60.
    Grissom CK, Morris AH, Lanken PN, Ancukiewicz M, Orme JF Jr, Schoenfeld DA, et al. Association of physical examination with pulmonary artery catheter parameters in acute lung injury. Crit Care Med. 2009;37:2720–6.PubMedPubMedCentralGoogle Scholar
  61. 61.
    Scheinman MM, Brown MA, Rapaport E. Critical assessment of use of central venous oxygen saturation as a mirror of mixed venous oxygen in severely ill cardiac patients. Circulation. 1969;40:165–72.PubMedGoogle Scholar
  62. 62.
    Goldman RH, Klughaupt M, Metcalf T, et al. Measurement of central venous oxygen saturation in patients with myocardial infarction. Circulation. 1968;38:941–6.PubMedGoogle Scholar
  63. 63.
    Ander DS, Jaggi M, Rivers E, Rady MY, Levine TB, Levine AB, et al. Undetected cardiogenic shock in patients with congestive heart failure presenting to the emergency department. Am J Cardiol. 1998;82:888–91.PubMedGoogle Scholar
  64. 64.
    Dueck M, Klimek M, Appenrodt S, Weigand C, Boerner U. Trends but not individual values of central venous oxygen saturation agree with mixed venous oxygen saturation during varying hemodynamic conditions. Anesthesiology. 2005;103:249–57.PubMedGoogle Scholar
  65. 65.
    Reinhart K, Rudolph T, Bredle DL, Hannemann L. Comparison of central-venous to mixed-venous oxygen saturation during changes in oxygen supply/demand. Chest. 1989;95:1216–21.PubMedGoogle Scholar
  66. 66.
    Reinhart K, Kuhn HJ, Hartog C, Bredle DL. Continuous central venous and pulmonary artery oxygen saturation monitoring in the critically ill. Intensive Care Med. 2004;30:1572–8.PubMedGoogle Scholar
  67. 67.
    Lamia B, Monnet X, Teboul JL. Meaning of arterio-venous PCO2 difference in circulatory shock. Minerva Anestesiol. 2006;72:597–604.PubMedGoogle Scholar
  68. 68.
    Mekontso-Dessap A, Castelain V, Anguel N, Bahloul M, Schauvliege F, Richard C, et al. Combination of venoarterial PCO2 difference with arteriovenous O2 content difference to detect anaerobic metabolism in patients. Intensive Care Med. 2002;28:272–7.PubMedGoogle Scholar
  69. 69.
    Ospina-Tascon GA, Umana M, Bermudez W, Bautista-Rincon DF, Hernandez G, Bruhn A, et al. Combination of arterial lactate levels and venous-arterial CO2 to arterial-venous O2 content difference ratio as markers of resuscitation in patients with septic shock. Intensive Care Med. 2015;41:796–805.PubMedPubMedCentralGoogle Scholar
  70. 70.
    Lim HS, Howell N. Cardiogenic shock due to end-stage heart faiure and acute myocardial infarction: characteristics and outcome of temporary mechanical circulatory support. Shock. 2018;50:167–72.PubMedGoogle Scholar
  71. 71.
    Jansen TC, van Bommel J, Schoonderbeek FJ, et al. LACTATE Study Group. Early lactate-guided therapy in intensive care unit patients: a multicenter, open-label, randomized controlled trial. Am J Respir Crit Care Med. 2010;182:752–61.PubMedGoogle Scholar
  72. 72.
    Hernandez G, Ospina-Tascon GA, Damiani LP, Estenssoro E, Dubin A, Hurtado J, et al. Effect of a resuscitation strategy targeting peripheral perfusion status vs serum lactate levels on 28-day mortality among patients with septic shock. The ANDROMEDA-SHOCK randomized clinical trial. JAMA. 2019;321:654–64.PubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.University Hospital Birmingham NHS Foundation TrustQueen Elizabeth Hospital BirmnghamBirminghamUK

Personalised recommendations